We only have this paper's title and publication details.
Read it at the sourceTranslational study reveals microRNA-5196 regulates profibrotic monocyte activity in systemic sclerosis, suggesting its potential as a diagnostic biomarker and therapeutic target.
No takes yet. Share an insight, caveat, or question.
Ciechomska et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: